Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from CVS Health ( (CVS) ) is now available.
On September 22, 2025, Omnicare, a subsidiary of CVS Health, initiated voluntary Chapter 11 proceedings to address financial challenges and resolve litigation issues from a recent court ruling that imposed significant monetary damages. This process aims to explore restructuring or sale options while ensuring the continued delivery of pharmacy services to long-term care facilities. Omnicare has secured $110 million in debtor-in-possession financing to maintain operations during the proceedings, ensuring liquidity to meet business obligations and uphold commitments to stakeholders.
The most recent analyst rating on (CVS) stock is a Buy with a $85.00 price target. To see the full list of analyst forecasts on CVS Health stock, see the CVS Stock Forecast page.
Spark’s Take on CVS Stock
According to Spark, TipRanks’ AI Analyst, CVS is a Outperform.
CVS Health’s strong technical momentum and positive earnings outlook are the most significant factors driving the score. While financial performance is solid, there is room for improvement in profitability. The valuation is reasonable, and the earnings call provided a positive outlook despite some challenges.
To see Spark’s full report on CVS stock, click here.
More about CVS Health
CVS Health is a leading health solutions company with approximately 9,000 retail pharmacy locations and over 1,000 walk-in and primary care clinics. It operates a leading pharmacy benefits manager serving 87 million plan members and provides senior pharmacy care to over 800,000 patients annually. CVS Health also offers health insurance products, including Medicare Advantage and Medicare Part D plans, using technology-driven services to enhance healthcare access, outcomes, and cost-efficiency.
Average Trading Volume: 7,676,864
Technical Sentiment Signal: Buy
Current Market Cap: $95.02B
For detailed information about CVS stock, go to TipRanks’ Stock Analysis page.